Safety and Efficacy of a Drug Eluting Slim Modiolar Electrode Array (NCT06598059)
A Pivotal, Prospective, Multicentre, Single-arm Study Evaluating the Safety and Efficacy of a Dexamethasone Eluting Slim Modiolar Electrode Array (EA32D).
🩺 Plain-English Summary (8th-Grade Level)
This clinical study will test a new type of cochlear implant known as CI632D. This experimental cochlear implant has been designed to slowly release a drug called dexamethasone. Dexamethasone works to ease inflammation and reduce tissue injury, which is common after any type of surgery. The goal is to learn if the dexamethasone in the CI632D implant lessens these reactions inside the ear following surgery and if this makes the implant work as well, or even better, in improving hearing than what would be expected with a standard cochlear implant. The study will be conducted in adults with sensorineural hearing loss, a type of hearing loss caused by damage to the inner ear or auditory nerve (the nerve that carries sound signals from the ear to the brain). The study participants will receive the CI632D experimental implant and will complete tests to see how well they are hearing and how well the implant is working.
Who can join: Review the eligibility criteria below.
Location: UCLA Medical Center — Los Angeles, California
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (11 Sites)
- UCLA Medical Center — Los Angeles, California
- Rocky Mountain Ear Center — Englewood, Colorado
- University of Iowa — Iowa City, Iowa
- Henry Ford Health — Detroit, Michigan
- Washington University — St Louis, Missouri
- New York Eye and Ear Infirmary — New York, New York
- NYU Langone Health — New York, New York
- Northwell Health Long Island Jewish Medical Center — New York, New York
- University Hospitals — Cleveland, Ohio
- Oregon Health & Science University — Portland, Oregon
- Medical University of South Carolina — Charleston, South Carolina
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Hearing Loss
- Improving Outcomes Using Technology for Children Who Are DHH — Aurora, Colorado
- Wind Noise Sound Quality Preference and Claims Study — Kitchener, Ontario
- Hearing Outcomes With the Nucleus® 8 Sound Processor and Nucleus® 7 Sound Processor in Adult Veteran and Non-veteran Cochlear Implant Recipients — Lone Tree, Colorado
- Evaluation of Investigational Hearing Instrument Features — Aurora, Illinois
- Automated Text Message Reminders to Promote Hearing Aid Adoption — Stanford, California
Explore by condition: All Hearing Loss clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.